Credit Agricole
TEVA icon

Credit Agricole’s Teva Pharmaceuticals TEVA Stock Holding History

Credit Agricole’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-70,000
Closed -$3.67M – 1621
2014
Q2 		$3.67M Buy
+70,000
New +$3.58M 0.02% 722

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Credit Agricole's TEVA Position: Q2 2026 in Review

Credit Agricole increased its Teva Pharmaceuticals (TEVA) stake by 2.5% in Q2 2026, buying an estimated $19.6K and bringing the position to 24,545 shares worth $832K. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

Credit Agricole first reported a position in TEVA in Q1 2014 and has held it in 45 quarters since. The position peaked at $67M in Q4 2015. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Credit Agricole held 24,545 shares of Teva Pharmaceuticals worth $832K as of Q2 2026.
  • Credit Agricole bought 589 Teva Pharmaceuticals shares in Q2 2026, an estimated $19.6K.
  • Teva Pharmaceuticals made up ﹤0.01% of Credit Agricole's portfolio in Q2 2026, its #1161 holding.
  • Credit Agricole first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 45 quarters since.
  • Credit Agricole's Teva Pharmaceuticals position peaked at $67M in Q4 2015.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.